Lorraine Webber is the UK Head of the Emerging Innovations Unit within AstraZeneca R&D. This is an externally-focussed R&D team primarily involved in drug re-purposing through pioneering ‘open innovation’ partnerships with a global network of external investigators, as well as internal drug repositioning. Lorraine has a broad background in drug development and has led drug projects in early clinical phase development in a number of therapy areas including respiratory, dermatology and women’s health. Lorraine has also held roles in the global commercial organisations at AstraZeneca and Novartis. Lorraine holds a degree in Medicine from Guy’s and St. Thomas’s Hospitals, London.